Popular Articles

Oncolytics Biotech(R) Inc. Announces Publication Of Research On Synergistic Activity Of Reovirus And Chemotherapy In NSCLC
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") reported today that Dr. Shizuko Sei et al. published the results of their work examining reovirus and chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled "Synergistic Antitumor Activity of Oncolytic Reovirus and Chemotherapeutic Agents in Non-Small Cell Lung Cancer Cells" appears online in the July 14, 2009 issue of Molecular Cancer.
generic viagra online
Scientists Link Elevated Insulin To Increased Breast Cancer Risk
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the online version of the International Journal of Cancer.
News of the day
Cell Phone Towers Can Help Predict The Next Big Flood
TAU research finds cell phone towers can help predict the next big flood
Public Health

Bariatric Surgery: Waiting Times Too Long In Canada

Obesity is now acknowledged as a chronic disease with a number of related complications, and its prevalence has reached alarming epidemic proportions. While bariatric surgery is effective at treating the disease, access to this procedure is still too limited in Canada. The latest article published by Dr. Nicolas Christou, of the McGill University Health Centre (MUHC), in the June issue of the Canadian Journal of Surgery assesses the waiting times for this procedure. According to the study, the average waiting time for bariatric surgery in Canada is 5 years, a timeframe that is long compared with the 8-week average for cancer surgery or the 18-month average for cosmetic surgery. Yet many studies have shown that this type of procedure reduces the risk of death over 5 years from 40% to 85%: bariatric surgery can therefore save lives. "Waiting times for bariatric surgery in Canada are much too long," Dr. Christou stated. "However, the provincial government"s recent announcement of additional money for our speciality is a positive and beneficial step. This funding will help us address our main obstacle, a lack of res, and therefore represents real hope for our patients." This investment should also have positive spinoffs in the medium-term for the health care system. Another article recently published by Dr. Christou in the World Journal of Surgery showed that bariatric surgery is the only treatment that ensures major and lasting weight loss. It can also significantly improve the long-term health of these patients by reducing their risk of developing obesity-related complications, such as diabetes, cancer, or heart and respiratory diseases. The costs to the health care system to treat these related pathologies would therefore decrease, and the initial investment would lead to savings within 3 years. Notes: The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santçİ du Quçİbec. Dr. Nicolas Christou Dr. Nicolas Christou is Director of Bariatric surgery at the MUHC and a researcher in the Infection and Immunity Axis of the Research Institute of the MUHC. He is also Professor of Surgery at the Faculty of Medicine of McGill University. Partners This article was co-authored by Dr. Nicolas Christou, MUHC, and Dr. Evangelos Efthimiou, MUHC. Isabelle Kling McGill University Health Centre


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):